Want to join the conversation?
$TSO 2Q15 Q&A: Cheng of Barclays asked about key financial metrics to look at in an M&A. Greg commented, most refining transactions that have occurred come into a close range on a DCF basis. Looking at opportunities would be looking at them from a discounted cash flow basis and second would be the embedded value in the business.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?